No abstract available
Publication types
-
Clinical Trial, Phase II
-
Letter
-
Randomized Controlled Trial
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adenine / analogs & derivatives*
-
Adenine / therapeutic use
-
Aged
-
Antineoplastic Agents, Immunological / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Chromosome Deletion
-
Chromosomes, Human, Pair 17 / genetics*
-
Female
-
Humans
-
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
-
Leukemia, Lymphocytic, Chronic, B-Cell / genetics
-
Male
-
Middle Aged
-
Mutation / drug effects
-
Piperidines / therapeutic use*
-
Protein Kinase Inhibitors / therapeutic use*
-
Remission Induction
-
Rituximab / therapeutic use
-
Tumor Suppressor Protein p53 / genetics*
Substances
-
Antineoplastic Agents, Immunological
-
Piperidines
-
Protein Kinase Inhibitors
-
TP53 protein, human
-
Tumor Suppressor Protein p53
-
ibrutinib
-
Rituximab
-
Adenine